Stockscreener 앱 받기
33.85
8.07%
-2.97
시간 외 거래:
33.85
전일 마감가:
$36.82
열려 있는:
$36.01
하루 거래량:
150.78K
Relative Volume:
0.67
시가총액:
$317.88M
수익:
-
순이익/손실:
$-81.17M
주가수익비율:
-3.3401
EPS:
-10.1344
순현금흐름:
$-82.84M
1주 성능:
-15.54%
1개월 성능:
-26.76%
6개월 성능:
+61.69%
1년 성능:
-43.71%
1일 변동 폭
$33.68
$38.42
1주일 범위
$33.68
$42.70
52주 변동 폭
$10.29
$76.79
Korro Bio Inc Stock (KRRO) Company Profile
명칭
Korro Bio Inc
전화
617-468-1999
주소
60 FIRST STREET, CAMBRIDGE
KRRO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KRRO
Korro Bio Inc
|
33.85 | 345.77M | 0 | -81.17M | -82.84M | -10.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Korro Bio Inc Stock (KRRO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-04-16 | 개시 | Chardan Capital Markets | Buy |
| 2025-01-10 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-08-14 | 개시 | William Blair | Outperform |
| 2024-03-28 | 재확인 | H.C. Wainwright | Buy |
| 2024-02-27 | 개시 | BMO Capital Markets | Outperform |
| 2023-12-04 | 개시 | H.C. Wainwright | Buy |
| 2023-11-29 | 개시 | RBC Capital Mkts | Outperform |
| 2023-11-10 | 개시 | Piper Sandler | Overweight |
| 2023-02-15 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2023-02-13 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2021-09-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-01-27 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2020-07-14 | 개시 | Oppenheimer | Outperform |
| 2020-05-18 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-10-28 | 개시 | Cowen | Outperform |
| 2019-10-28 | 개시 | Goldman | Buy |
| 2019-10-28 | 개시 | JP Morgan | Overweight |
모두보기
Korro Bio Inc 주식(KRRO)의 최신 뉴스
Automated trading signals detected on Korro Bio Inc.Weekly Profit Analysis & Trade Opportunity Analysis Reports - newser.com
Can Korro Bio Inc. stock hit record highs again2025 Winners & Losers & Verified Technical Signals - newser.com
What high frequency data says about Korro Bio Inc.Take Profit & Consistent Growth Equity Picks - newser.com
Will Korro Bio Inc. stock attract more institutional investorsTrade Ideas & Scalable Portfolio Growth Methods - newser.com
Will Korro Bio Inc. stock benefit from automationMarket Performance Summary & Verified Technical Signals - newser.com
Custom strategy builders for tracking Korro Bio Inc.2025 Big Picture & Entry Point Confirmation Signals - newser.com
Will Korro Bio Inc. stock recover faster than marketRisk Management & Weekly Stock Performance Updates - newser.com
What indicators show strength in Korro Bio Inc.Earnings Risk Report & Precise Trade Entry Recommendations - newser.com
What makes Korro Bio Inc. stock attractive to growth funds2025 Dividend Review & Weekly Market Pulse Updates - newser.com
How to track smart money flows in Korro Bio Inc.Weekly Trend Report & Smart Money Movement Alerts - newser.com
What is the fair value of Korro Bio Inc. stock nowJuly 2025 Weekly Recap & Community Supported Trade Ideas - newser.com
Trend analysis for Korro Bio Inc. this weekMarket Volume Summary & AI Enhanced Trading Signals - newser.com
Can Korro Bio Inc. stock double in next 5 yearsMarket Movers & AI Optimized Trading Strategy Guides - newser.com
Risk vs reward if holding onto Korro Bio Inc.2025 Price Momentum & High Return Stock Watch Alerts - newser.com
Is Korro Bio Inc. stock positioned for long term growthJuly 2025 Earnings & Stepwise Swing Trade Plans - newser.com
Why Korro Bio Inc. stock is favored by pension fundsPortfolio Risk Summary & Long-Term Safe Investment Plans - newser.com
Korro Bio’s KRRO-110 Study: A Potential Game-Changer in Genetic Therapy - MSN
Published on: 2025-11-01 04:19:56 - newser.com
Will Korro Bio Inc. stock deliver strong dividend growthWeekly Stock Analysis & Weekly Setup with High ROI Potential - newser.com
Why retail investors pile into Korro Bio Inc. stockJuly 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Clear Street Initiates Coverage of Korro Bio (KRRO) with Buy Recommendation - Nasdaq
This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Key resistance and support levels for Korro Bio Inc.July 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Clear Street initiates Korro Bio stock with Buy rating, $93 price target - Investing.com Australia
Clear Street initiates Korro Bio stock with Buy rating, $93 price target By Investing.com - Investing.com South Africa
Korro Bio Inc (KRRO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Korro Bio Inc 주식 (KRRO) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Agarwal Vineet | Chief Financial Officer |
Nov 11 '24 |
Sale |
70.00 |
800 |
56,000 |
0 |
1.45%
0.86%
자본화:
|
볼륨(24시간):